Adjuvant Therapy in Malignant Melanoma: A Trial of Immunotherapy, Chemotherapy, and Combined Treatment
- 1 January 1979
- book chapter
- Published by Springer Nature
- Vol. 68, 380-386
- https://doi.org/10.1007/978-3-642-81332-0_57
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Immunotherapy as an adjunct to surgery in the treatment of cancerWorld Journal of Surgery, 1977
- Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanomaCancer, 1977
- Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanomaCancer, 1977
- Adjuvant Immunotherapy with BCG in Treatment of Regional-Lymph-Node Metastases from Malignant MelanomaNew England Journal of Medicine, 1976
- Tumor Thickness, Level of Invasion and Node Dissection in Stage I Cutaneous MelanomaAnnals of Surgery, 1975
- Regression of pulmonary metastatic disease associated with intralesional bcg therapy of intracutaneous melanoma metastasesCancer, 1975
- Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-GuérinNew England Journal of Medicine, 1974
- Complications of BCG Immunotherapy in Patients with CancerNew England Journal of Medicine, 1973
- ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMAThe Lancet, 1973
- Maximum utilization of the life table method in analyzing survivalJournal of Chronic Diseases, 1958